Domingues, R. G., Lago-Baldaia, I., Pereira-Castro, I., Fachini, J. M., et al. (2016). CD5 expression is regulated during human T-cell activation by alternative polyadenylation, PTBP1, and miR-204. European Journal of Immunology, 46(6), 1490 - 1503.

Pinto, M., & Carmo, A. M. (2013). CD6 as a therapeutic target in autoimmune diseases: Successes and challenges. BioDrugs, 27(3), 191 - 202.

Oliveira, M. I., Gonçalves, C. M., Pinto, M., Fabre, S., et al. (2012). CD6 attenuates early and late signaling events, setting thresholds for T-cell activation. European Journal of Immunology, 42(1), 195 - 205.

Kearney, A., Avramovic, A., Castro, M. A. A., Carmo, A. M., et al. (2007). The contribution of conformational adjustments and long-range electrostatic forces to the CD2/CD58 interaction. Journal of Biological Chemistry, 282(18), 13160 - 13166.

Evans, E. J., Castro, M. A. A., O'Brien, R., Kearney, A., et al. (2006). Crystal structure and binding properties of the CD2 and CD244 (2B4)-binding protein, CD48. Journal of Biological Chemistry, 281(39), 29309 - 29320.